✦ LIBER ✦

Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?

✍ Scribed by Johnson, Faye M.; Glisson, Bonnie S.

Book ID: 111655573
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 123 KB
Volume: 6
Category: Article
ISSN: 1759-4774
DOI: 10.1038/nrclinonc.2009.141

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan (T) as second-line therapy fol

Topotecan (T) as second-line therapy following ifosfamide-carboplatin-etoposide (ICE) and maintenance for small cell lung cancer (SCLC)

✍ Ruotsalainen, T; Mattson, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

CHOP plus etoposide and gemcitabine (CHO

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

✍ Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Dong Hwan Kim; Jin Ho Baek; Kyu Bo 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 199 KB

Combination of topotecan and etoposide a

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy

✍ Hye Jin Choi; Byoung Chul Cho; Sang Joon Shin; Seong Ha Cheon; Jong Yul Jung; Jo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 245 KB

SCOTROC 2B: feasibility of carboplatin f

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

P-778 A phase II trial of carboplatin an

P-778 A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results

✍ Laskin, J.; Shirley, B.; Dobbs, T.; Bi, J.; Carbone, D.; Johnson, D.; Sandler, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Front-line chemotherapy with cisplatin a

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma : A prospective study

✍ Vittorio Franciosi; Giorgio Cocconi; Maria Michiara; Francesco Di Costanzo; Vini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## BACKGROUND. The conventional treatment of brain metastases not amenable to surgery is most often radiotherapy. Until now, pharmacologic issues related to the blood brain barrier (BBB) prevented a wide evaluation of chemotherapy. The authors previously reported that the combination of cisplatin